IDDI / Corporate Presentation eClinical and Biostatistical Services

Company History

20111996 2001 2004 20061991

SARL, Paris

Operations centered in

Belgium

2010

Inc.

2010

Inc.

Houston, TX, USACambridge, MA, USA

IDDI , a Clinical Data Center

The mission of IDDI is to deliver clinical trial results that are

scientifically accurate, validated and reproducible.

3

Expertise

Consultancy

Clinical trial program strategy, protocol design, expert mission with regulatory agencies

Randomization and Drug Supply Management

(e)-CRF Design and Data ManagementBiostatistical Services

Biostatistical AnalysesMeta-analyses

Biomarkers QualificationIDMC supportMedical Writing

Web systems

eClinical Suite

Central Randomization (ID-net™) and Treatment Allocation (ID-supply™)Data Management (EDC) integrated with ID-net™Coding of Medical Terms (ID-code™)

Secured sharing of documents and data (TrialControl™)Validation of systemsCustomer support

Global Experience (> 2002)

500+ Phase I-IV trials160+ Randomization systems in

100+ countries 50,000+ patients 6,000+ sites

350+ Publications400+ Scientific presentations10 Scientific seminars since 20038 Webinars since 2010

6

Client Base

+75% repeat business!

Academic Group17%

Biotechnology56%

Pharmaceu-tical24%

Other (Medical Devices, Nutri-tion…)

3%

Over the last 5 years IDDI worked with 110+ clients worldwide

Currently 75 clients – 180 projects

FDA / EMA approvals

Involvement in

15

FDA/EMA approvals

and currently working on 30+ studies to be used in submission dossiers in the US and/or Europe

8

Experience by Sponsor’s Origin (#of trials over the last 5 years)

9

ASIA 1%

GERMANY2%

NORWAY/SWEDEN/DENMARK3%

UNITED KINGDOM

7%

CANADA9%

SWITZERLAND11%

BELGIUM / NETHERLANDS

15%

FRANCE21%

USA31%

Experience by Phase (#of trials over the last 5 years)

10

Multiple Phase11%

Phase I13%

Phase I/II2%

Phase II27%

Phase II/III3%

Phase III36%

Phase IV8%

Experience by Therapeutic Area

(#of trials over the last 5 years)

11

Dermatology1%

Endocrine/Metabolic Diseases

1%

Musculoskeletal1%

Multiple 2% Gastroenterology

2%Immunology/

Vaccines2%

CNS 2%

Infectious Diseases4%

Cardio-vascular/ Cardiology

9%

Ophthalmology13%Oncology

63%

Why IDDI?

IDDI's Added Value

Team of talented professionals with extensive scientific depthDedicated staff with virtually no turnoverRobust, flexible, cost-effective EDC and IWR solutions20 years in the clinical research businessRecognized expertise in oncologyTrack record of success stories Extensive regulatory experience with involvement in 15 FDA/EMA approvalsWorldwide reputation and scientific visibilityIndependent status

13